Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil

Clinical trial NCT05959720 · RECRUITING

Trial details

NCT number: NCT05959720
Sponsor: Instituto do Cancer do Estado de São Paulo
Status: RECRUITING
Study type: OBSERVATIONAL

Acute Lymphoid Leukemia Minimal Residual Disease Gene Abnormality Chemotherapeutic Toxicity

Start date: 2023-09-05
Primary completion: 2028-06-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.